Opiant Pharmaceuticals/ US6837501039 /
2023-03-01 10:00:00 PM | Chg. - | Volume | Bid1:50:09 AM | Ask1:50:09 AM | High | Low |
---|---|---|---|---|---|---|
20.6500USD | - | 562,778 Turnover: 9.76 mill. |
20.8000Bid Size: - | 24.9900Ask Size: - | 21.0000 | 20.5000 |
GlobeNewswire
2022-03-15
Opiant Pharmaceuticals Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Co...
GlobeNewswire
2022-03-10
Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference
GlobeNewswire
2022-03-07
Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and ...
GlobeNewswire
2022-01-24
Opiant Pharmaceuticals Announces Additional $2.2 million Funding Under BARDA Contract for OPNT003 Na...
GlobeNewswire
2022-01-20
Opiant Pharmaceuticals Announces First Patient Dosed in Phase 2 Trial of OPNT002, Nasal Naltrexone, ...
GlobeNewswire
2022-01-20
Correction: Opiant Pharmaceuticals Corrects Error in Issuing Duplicate Press Release Today
GlobeNewswire
2021-11-11
Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-11-10
Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference
GlobeNewswire
2021-11-04
Opiant Receives FDA Fast Track Designation for OPNT003, Nasal Nalmefene, for Treatment of Opioid Ove...
GlobeNewswire
2021-11-03
180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
GlobeNewswire
2021-11-02
Opiant Announces Publication of Manuscript Treatment of Overdose in the Synthetic Opioid Era in Peer...
GlobeNewswire
2021-10-21
Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and W...
GlobeNewswire
2021-08-05
Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-07-22
Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and ...
GlobeNewswire
2021-07-12
Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer
GlobeNewswire
2021-07-06
Opiant Pharmaceuticals Announces Positive Top-line Results of Confirmatory Pharmacokinetic (PK) Stud...
GlobeNewswire
2021-05-24
Opiant Pharmaceuticals to Present at the 2021 Jefferies Virtual Healthcare Conference
GlobeNewswire
2021-05-18
Opiant Pharmaceuticals to Hold Virtual 2021 Annual Shareholder Meeting on Tuesday, June 15, 2021 at ...
GlobeNewswire
2021-05-11
Opiant Pharmaceuticals Announces First Quarter 2021 Financial Results and Corporate Update